Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Meyer

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|June 1, 1976
Antiviral agents: a perspective on research and regulationH M Meyer
Human Pathology|June 1, 1973
Status of the CEA testH M Meyer
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Comment: Thioridazine bioequivalenceH M Meyer
Public Health Reports (Washington, D.C. : 1974)|July 1, 1983
Food and Drug Administration responses to the challenges of AIDSH M Meyer
Transplantation Proceedings|June 1, 1976
Standards for tissue banks and transplantationH M Meyer
Advances in Experimental Medicine and Biology|January 1, 1979
Cell substrates. Their use in the production of vaccines and other biologicals. Past achievements - future expectationsH M Meyer
The Journal of Infectious Diseases|August 1, 1980
Rabies vaccineH M Meyer
Cancer Research|February 11, 1976
Regulatory approach toward vaccines against cancer: the benefit/risk ratioH M Meyer, F A Ennis
JAMA|January 25, 1971
Rubella vaccination. A review of practical experienceH M Meyer, P D Parkman
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1973
Abortive replication of CV1 strain of vaccinia virus in human embryo kidney cellsR C Dunlap, H M Meyer
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|June 1, 1976
Antiviral agents: a perspective on research and regulationH M Meyer
Human Pathology|June 1, 1973
Status of the CEA testH M Meyer
Drug Intelligence & Clinical Pharmacy|April 1, 1986
Comment: Thioridazine bioequivalenceH M Meyer
Public Health Reports (Washington, D.C. : 1974)|July 1, 1983
Food and Drug Administration responses to the challenges of AIDSH M Meyer
Transplantation Proceedings|June 1, 1976
Standards for tissue banks and transplantationH M Meyer
Advances in Experimental Medicine and Biology|January 1, 1979
Cell substrates. Their use in the production of vaccines and other biologicals. Past achievements - future expectationsH M Meyer
The Journal of Infectious Diseases|August 1, 1980
Rabies vaccineH M Meyer
Cancer Research|February 11, 1976
Regulatory approach toward vaccines against cancer: the benefit/risk ratioH M Meyer, F A Ennis
JAMA|January 25, 1971
Rubella vaccination. A review of practical experienceH M Meyer, P D Parkman
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 1, 1973
Abortive replication of CV1 strain of vaccinia virus in human embryo kidney cellsR C Dunlap, H M Meyer
Pageof 5